Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver ...
With investors rushing to secure Venture Capital Trust (VCT) allocations ahead of the expected reduction in the 30% income tax relief, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果